Literature DB >> 33802569

mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.

Sumit Mukherjee1, Bodhisattwa Banerjee2, David Karasik2, Milana Frenkel-Morgenstern1.   

Abstract

The recently emerged SARS-CoV-2 virus is responsible for the ongoing COVID-19 pandemic that has rapidly developed into a global public health threat. Patients severely affected with COVID-19 present distinct clinical features, including acute respiratory disorder, neutrophilia, cytokine storm, and sepsis. In addition, multiple pro-inflammatory cytokines are found in the plasma of such patients. Transcriptome sequencing of different specimens obtained from patients suffering from severe episodes of COVID-19 shows dynamics in terms of their immune responses. However, those host factors required for SARS-CoV-2 propagation and the underlying molecular mechanisms responsible for dysfunctional immune responses during COVID-19 infection remain elusive. In the present study, we analyzed the mRNA-long non-coding RNA (lncRNA) co-expression network derived from publicly available SARS-CoV-2-infected transcriptome data of human lung epithelial cell lines and bronchoalveolar lavage fluid (BALF) from COVID-19 patients. Through co-expression network analysis, we identified four differentially expressed lncRNAs strongly correlated with genes involved in various immune-related pathways crucial for cytokine signaling. Our findings suggest that the aberrant expression of these four lncRNAs can be associated with cytokine storms and anti-viral responses during severe SARS-CoV-2 infection of the lungs. Thus, the present study uncovers molecular interactions behind the cytokine storm activation potentially responsible for hyper-inflammatory responses in critical COVID-19 patients.

Entities:  

Keywords:  COVID-19; co-expression network; cytokine storm; lncRNA

Mesh:

Substances:

Year:  2021        PMID: 33802569      PMCID: PMC7999169          DOI: 10.3390/v13030402

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  49 in total

1.  TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection.

Authors:  Edward Tobinick
Journal:  Curr Med Res Opin       Date:  2004-01       Impact factor: 2.580

2.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads.

Authors:  Mihaela Pertea; Geo M Pertea; Corina M Antonescu; Tsung-Cheng Chang; Joshua T Mendell; Steven L Salzberg
Journal:  Nat Biotechnol       Date:  2015-02-18       Impact factor: 54.908

3.  In the eye of the COVID-19 cytokine storm.

Authors:  Natalie Vaninov
Journal:  Nat Rev Immunol       Date:  2020-05       Impact factor: 53.106

4.  An inflammatory cytokine signature predicts COVID-19 severity and survival.

Authors:  Diane Marie Del Valle; Seunghee Kim-Schulze; Hsin-Hui Huang; Noam D Beckmann; Sharon Nirenberg; Bo Wang; Yonit Lavin; Talia H Swartz; Deepu Madduri; Aryeh Stock; Thomas U Marron; Hui Xie; Manishkumar Patel; Kevin Tuballes; Oliver Van Oekelen; Adeeb Rahman; Patricia Kovatch; Judith A Aberg; Eric Schadt; Sundar Jagannath; Madhu Mazumdar; Alexander W Charney; Adolfo Firpo-Betancourt; Damodara Rao Mendu; Jeffrey Jhang; David Reich; Keith Sigel; Carlos Cordon-Cardo; Marc Feldmann; Samir Parekh; Miriam Merad; Sacha Gnjatic
Journal:  Nat Med       Date:  2020-08-24       Impact factor: 53.440

5.  Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication.

Authors:  Elena Carnero; Marina Barriocanal; Celia Prior; Juan Pablo Unfried; Victor Segura; Elizabeth Guruceaga; Mónica Enguita; Cristian Smerdou; Pablo Gastaminza; Puri Fortes
Journal:  EMBO Rep       Date:  2016-06-09       Impact factor: 8.807

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 7.  The cytokine storm and COVID-19.

Authors:  Biying Hu; Shaoying Huang; Lianghong Yin
Journal:  J Med Virol       Date:  2020-09-30       Impact factor: 20.693

Review 8.  Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.

Authors:  Antonella Fara; Zan Mitrev; Rodney Alexander Rosalia; Bakri M Assas
Journal:  Open Biol       Date:  2020-09-23       Impact factor: 6.411

9.  Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

Authors:  Barry Rockx; Thijs Kuiken; Sander Herfst; Theo Bestebroer; Mart M Lamers; Bas B Oude Munnink; Dennis de Meulder; Geert van Amerongen; Judith van den Brand; Nisreen M A Okba; Debby Schipper; Peter van Run; Lonneke Leijten; Reina Sikkema; Ernst Verschoor; Babs Verstrepen; Willy Bogers; Jan Langermans; Christian Drosten; Martje Fentener van Vlissingen; Ron Fouchier; Rik de Swart; Marion Koopmans; Bart L Haagmans
Journal:  Science       Date:  2020-04-17       Impact factor: 47.728

View more
  8 in total

1.  Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.

Authors:  Dinesh Devadoss; Arpan Acharya; Marko Manevski; Dominika Houserova; Michael D Cioffi; Kabita Pandey; Madhavan Nair; Prem Chapagain; Mehdi Mirsaeidi; Glen M Borchert; Siddappa N Byrareddy; Hitendra S Chand
Journal:  iScience       Date:  2022-06-30

Review 2.  SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.

Authors:  Lucia Natarelli; Fabio Virgili; Christian Weber
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

3.  Deregulation of ceRNA Networks in Frontal Cortex and Choroid Plexus of Brain during SARS-CoV-2 Infection Aggravates Neurological Manifestations: An Insight from Bulk and Single-Cell Transcriptomic Analyses.

Authors:  Deepyaman Das; Soumita Podder
Journal:  Adv Biol (Weinh)       Date:  2022-06-03

4.  Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19.

Authors:  Zahra Firoozi; Elham Mohammadisoleimani; Abbas Shahi; Mohammad Mehdi Naghizadeh; Ebrahim Mirzaei; Ali Ghanbari Asad; Zahra Salmanpour; Seyed Mohamad Javad Nouri; Yaser Mansoori
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-08-30       Impact factor: 2.585

5.  Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.

Authors:  Jingchao Liu; Jingyi Cui; Shuangyi Zhao; Meng Wu; Jiawen Wang; Yaoguang Zhang; Bin Jin; Jianye Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-29       Impact factor: 7.310

Review 6.  Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection.

Authors:  Yichen Zhong; Caroline L Ashley; Megan Steain; Sandro Fernandes Ataide
Journal:  Front Mol Biosci       Date:  2022-08-16

Review 7.  Current understanding on long non-coding RNAs in immune response to COVID-19.

Authors:  Jing Ding; Xude Yin; Jing Chen; Jin Zhou
Journal:  Virus Res       Date:  2022-10-05       Impact factor: 6.286

8.  Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis.

Authors:  Chinmay Saha; Sayantan Laha; Raghunath Chatterjee; Nitai P Bhattacharyya
Journal:  Noncoding RNA       Date:  2021-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.